Open Air Scholar

Design:

The study employed a multi-faceted approach, combining human clinical data, murine models (wildtype and CFTR-deficient Cftr−/− mice), in vitro experiments with human CF airway epithelial cells (CuFi) and non-CF controls (NuLi), and RNA sequencing. Retrospective analysis of electronic health records (EHR) evaluated clinical outcomes in CF patients. Murine models were challenged with Alternaria alternata extract (AE) to simulate allergen exposure. Genetic knockout models (IL-33−/−, ST2−/−, and T cell-specific Cftr−/− mice) were used to dissect pathway dependencies. CFTR modulators, including triple combinations (elexacaftor/tezacaftor/ivacaftor), were tested for therapeutic effects.

Procedures:

Key interventions included allergen challenge (AE) in mice, pharmacological inhibition of DUOX1 (a hydrogen peroxide-generating enzyme), and CFTR modulator administration. Outcomes measured included serum IgE, blood and BALF eosinophil counts, lung histopathology (e.g., goblet cell hyperplasia, vascular remodeling), cytokine production (IL-5, IL-13, CXCL1), and transcriptomic analysis of Th2 cells. Statistical analyses compared CF patients with non-CF controls and assessed associations between type 2 biomarkers and clinical severity (e.g., FEV1, infection rates, mortality).

Primary Findings:

CF patients exhibited elevated serum IgE and blood eosinophil counts compared to non-CF controls, indicating heightened type 2 activity. Retrospective EHR analysis revealed that CF patients with IgE ≥100 IU/mL or eosinophils ≥300/μL had more severe pulmonary dysfunction (reduced FEV1 and FEV1/FVC ratios), higher infection rates (Pseudomonas aeruginosa, Staphylococcus aureus, Aspergillus), and a 2.26-fold increased mortality risk. In murine models, Cftr−/− mice exposed to AE showed elevated IL-33 in lung tissue and BAL fluid, driven by increased DUOX1 expression. IL-33/ST2 deficiency in Cftr−/− mice reduced AE-induced eosinophilia, goblet cell hyperplasia, and neutrophil influx. CFTR-deficient Th2 cells produced heightened IL-4, IL-5, and IL-13, linked to upregulated IL-4Rα and GATA3. CFTR modulators (e.g., ivacaftor) reduced IgE, eosinophils, and Th2 cytokines in both mice and humanized models.

Secondary Findings:

DUOX1 inhibition normalized IL-33 secretion in Cftr−/− mice, implicating oxidative stress in IL-33 release. RNA sequencing of Th2 cells revealed a hyper-Th2 transcriptome in CFTR-deficient cells, with enhanced IL-4/GATA3 signaling. CFTR loss in T cells alone (CD4Cre+Cftrfl/fl mice) amplified allergic inflammation, independent of epithelial CFTR status. Clinical genetic analysis identified IL-33 pathway modifiers associated with CF lung disease severity.

Interpretation:

CFTR deficiency creates a pro-inflammatory microenvironment by dysregulating epithelial IL-33 release and enhancing Th2 cell hyperresponsiveness. IL-33, released from stressed CFTR-deficient epithelia, activates ILC2 and Th2 cells, driving eosinophilia, IgE elevation, and tissue remodeling. DUOX1-mediated oxidative stress amplifies IL-33 secretion, while CFTR modulators mitigate this by restoring epithelial function and suppressing T cell hyperactivity. The dual role of type 2 immunity—potentially protective against pathogens but maladaptive in CF—requires further exploration.

Strengths:

The study integrates clinical, preclinical, and mechanistic data, validating findings across human and murine models. Use of genetic knockout models and CFTR modulators strengthens causal inferences. Identification of IL-33/ST2 and DUOX1 as therapeutic targets provides actionable insights.

Limitations:

Extrapolation of murine findings to human CF may be limited by species-specific differences in immune responses. The study focuses on type 2 inflammation but does not fully address interactions with neutrophilic pathways. Long-term effects of CFTR modulators on immune dysregulation remain understudied.

Design:

The study employed a combination of experimental and computational approaches to analyze engineered variants of the PNT3 domain. Key variants included PNT3tr mutants (lysine-to-arginine substitutions, KallR; arginine-to-lysine substitutions, RallK), hydrophobic variants (glycine-to-valine substitutions, GallV; valine/isoleucine/leucine-to-glycine substitutions, VILallG), and charge-modified full-length PNT3 variants (high-κ clustered charges vs. low-κ distributed charges). Researchers used biophysical techniques such as thioflavin T (ThT) binding assays, Raman spectroscopy, circular dichroism (CD), small-angle X-ray scattering (SAXS), and tyrosine Fermi doublet analysis to characterize structural changes and aggregation behavior. Bioinformatics tools (MEtserver, FoldAmyloid) were applied to predict amyloidogenic potential and phase separation.

Procedures:

Engineered variants were subjected to fibrillation assays to assess aggregation kinetics and solubility. Structural analyses included Raman spectroscopy to quantify β-sheet content and aromatic interactions, CD to detect secondary structure transitions, and SAXS to determine conformational states (e.g., Stokes radius and radius of gyration, Rg). Tyrosine Fermi doublet ratios (850/830 cm⁻¹) were measured to evaluate π-π stacking in fibrils. Redox conditions were tested to explore their impact on structural transitions and amyloid formation. Wild-type and variant proteins were compared under physiological conditions to identify key residues and spatial arrangements influencing fibrillation.

Primary Findings:

RallK exhibited reduced compaction (compaction index, CI=0.44) and formed α-helices (15%) and β-strands (29%), while VILallG was more compact (CI=0.60) with 34% β-strands. Despite high amyloidogenic potential, GallV lacked secondary structure changes, suggesting nucleation without full transition to β-sheets. Fibrillation assays revealed RallK formed abundant, highly soluble fibrils, whereas KallR was insoluble and poorly fibrillated. GallV nucleated rapidly but produced short fibrils, while VILallG generated long fibrils despite low hydrophobicity. Raman spectroscopy confirmed β-sheet structures in all fibrils, with RallK showing stronger hydrogen bonding (Amide I full width at half maximum, FWHM=44 cm⁻¹ vs. wild-type 53 cm⁻¹). The high-κ variant (clustered charges) adopted a compact, pre-molten globule-like conformation (Stokes radius 27.7 Å, SAXS Rg 31.3 Å), while low-κ (evenly distributed charges) remained extended (Stokes radius 28.9 Å, SAXS Rg 38.2 Å), resembling an intrinsically disordered protein (IDP). Low-κ variants displayed abundant fibrils with high ThT binding, whereas high-κ variants showed similar ThT fluorescence but no visible fibrils, indicating non-specific aggregation.

Secondary Findings:

Far-UV CD spectroscopy revealed no secondary structure changes in wild-type PNT3 and low-κ variants, conflicting with Raman data that detected β-sheet enrichment in RallK. This discrepancy suggests that CD may not detect subtle structural transitions in disordered regions. The N-terminal domain (NTD) of the W protein was found to adopt a compact, elongated conformation under physiological conditions, while the C-terminal domain (CTD) remained flexible. Redox conditions influenced phase separation and amyloid formation, with oxidizing environments promoting structural changes. Bioinformatics tools failed to predict the behavior of κ variants, highlighting limitations in computational modeling of complex aggregation dynamics.

Interpretation:

The study demonstrates that lysine plays a critical role in solubility and fibrillation, with its spatial distribution determining aggregation outcomes. RallK’s enhanced β-sheet content (77.2%) and reduced disorder (22.8%) suggest that arginine substitutions promote ordered amyloid-like structures, while clustered charges (high-κ) suppress fibrillation by maintaining compactness. Conversely, low-κ variants, with evenly distributed charges, adopt extended conformations that facilitate aggregation. Hydrophobic residues drive nucleation but do not solely dictate fibril length or stability, as VILallG (reduced hydrophobicity) formed long fibrils. The lack of secondary structure changes in CD for low-κ variants underscores the importance of multi-method approaches to capture structural heterogeneity. Redox-dependent structural transitions in the W protein’s domains may enable viral immune evasion by modulating phase separation and aggregation.

Strengths:

The study’s multi-method design (Raman, CD, SAXS, TEM) provided a comprehensive view of structural and aggregation dynamics. Engineered variants systematically tested the roles of basic and hydrophobic residues, revealing nuanced interactions between electrostatics and hydrophobicity. The inclusion of bioinformatics tools and their limitations underscores the need for experimental validation in amyloid research.

Limitations:

Computational predictions (e.g., MEtserver, FoldAmyloid) could not fully explain the κ variants’ behavior, suggesting gaps in modeling charge distribution effects. In vitro assays may not fully replicate in vivo redox environments, limiting conclusions about viral pathogenesis. The study did not explore the functional consequences of these structural changes on viral replication or immune evasion.

Implications:

The findings highlight the potential of targeting residue-specific interactions (e.g., lysine, hydrophobic patches) to disrupt viral amyloid formation, which may be critical for Hendra virus pathogenesis. Understanding how charge clustering modulates aggregation could inform strategies to inhibit viral proteins’ phase separation, a process linked to immune evasion. Structural insights into the NTD and CTD of the W protein suggest that redox-sensitive regions might be therapeutic targets to block amyloid-driven processes.

Design:

The study combined structural biology, genetic, biochemical, and computational approaches. Key experiments included cryo-electron microscopy (cryo-EM), mass photometry, transcriptional assays, mutagenesis, and in vitro DNA binding studies. Bacterial strains with and without Stl2 were tested for phage sensitivity, while small molecules like suramin were used to disrupt Stl2-Sak80α interactions. Computational tools such as cryoSPARC, UCSF ChimeraX, and PHENIX were employed for structural analysis.

Procedures:

Structural characterization of Stl2 oligomers and complexes with HRs was performed via cryo-EM and mass photometry. Transcriptional repression assays measured SaPI2 gene expression in the presence/absence of Stl2. Mutagenesis targeted Stl2's dimerization interfaces and Sak80α's C-terminal domain. Fluorescent DNase I footprinting identified Stl2-DNA binding sites, while β-lactamase assays quantified phage sensitivity. In vivo experiments tested SaPI transfer efficiency in stl2 mutants. Comparative genomics analyzed Stl2 homologs across 20 bacterial species.

Primary Findings:

Stl2 forms dimers, rings (11–13 protomers), and filaments through oligomerization mediated by its N-terminal α-helices and C-terminal β-sheets. Cryo-EM revealed Stl2 decorates Sak80α rings (17-mer) and binds Sak452A filaments, disrupting their functional oligomers. Stl2 mutants lacking dimer interfaces lost oligomerization and DNA binding but retained transcriptional repression, indicating structural mimicry is critical for HR inhibition. Strains lacking Stl2 lost immunity to phages 80α, 52A, and 53, while ectopic Sak80α expression restored phage sensitivity. Stl2-Sak80α complexes stabilized Sak80α's C-terminal domain in two conformations, blocking DNA and SSB80α interactions. In vitro assays showed Stl2 inhibits Sak80α-mediated DNA annealing, with SSB80α enhancing this effect.

Secondary Findings:

Stl2 binds Sak80α via conserved surface grooves, with critical residues identified through mutagenesis. Mass photometry confirmed a 1:1 Stl2-Sak80α stoichiometry (Kd ~1–10 µM). Comparative genomics revealed conserved DNA-binding domains in Stl2 homologs but variable C-terminal regions, suggesting adaptive evolution. Phylogenetic analysis indicated co-evolution of Stl2-like proteins with Sak terminases. Small molecules like suramin disrupted Stl2-Sak80α interactions, inhibiting SaPI mobility and offering therapeutic potential against horizontal gene transfer of virulence factors.

Interpretation:

Stl2's dual role as a transcriptional repressor and structural mimic enables broad antiviral activity by simultaneously suppressing SaPI2 lytic genes and disrupting phage HR function. The structural mimicry mechanism represents a novel strategy distinct from CRISPR systems, relying on oligomerization to block HR assembly. The Stl2-Sak80α interaction acts as a molecular checkpoint, delaying SaPI activation until sufficient phage terminase assembles, preventing premature host lysis. This regulatory interplay underscores an evolutionary arms race between SaPIs and phages.

Strengths:

The study integrates structural, genetic, and biochemical data to provide a mechanistic understanding of Stl2's function. The use of cryo-EM and mass photometry enabled detailed visualization of protein complexes, while mutagenesis validated critical residues. The discovery of suramin's inhibitory effect on Stl2-Sak80α interactions highlights translational potential.

Limitations:

The study focuses on specific phages (80α, 52A, 53) and HR proteins; broader applicability to other phages or HR families requires further testing. In vivo relevance in natural S. aureus populations and clinical settings remains to be explored. The role of Stl2 in other pathogenicity islands or bacterial species also warrants investigation.

Design:

The study employed a multi-faceted approach combining in vitro experiments, in vivo mouse models, and analysis of public datasets. Mouse models included Gprc5a–/– mice (prone to lung tumors) with NF-κB suppression via the SPC-dnIκBα transgene. Human and murine lung epithelial cell lines (e.g., A549, MTEC) were used for in vitro studies. Public datasets (e.g., TCGA, GEO) were analyzed to correlate EAAT3 expression with NF-κB activity and smoking exposure.

Procedures:

Key methods included chromatin immunoprecipitation (ChIP) and luciferase reporter assays to identify NF-κB binding sites in the EAAT3 promoter. ROS levels were measured using CellROX fluorescence, while cystine uptake assays quantified Xc⁻ system activity. Ferroptosis sensitivity was assessed via RSL3 treatment and transmission electron microscopy (TEM) for mitochondrial damage analysis. Immunohistochemistry (IHC) and co-immunoprecipitation (Co-IP) evaluated protein expression and interactions. NF-κB inhibitors (BMS345541, QNZ) and siRNA targeting P65 (NF-κB subunit) were used to suppress signaling. Smoking-induced inflammation was modeled using cigarette smoke extract (CSE) and nicotine-derived nitrosamine ketone (NNK).

Primary Findings:

NF-κB directly induces EAAT3 expression through two cis-elements (p1 and p2) in its promoter, confirmed by ChIP and luciferase assays. Inhibition of NF-κB (via QNZ or siRNA) or EAAT3 knockdown increased reactive oxygen species (ROS) and sensitized cells to ferroptosis inducers like RSL3. In Gprc5a–/– mice with NF-κB suppression, Eaat3 expression and tumor burden were reduced. Public datasets revealed EAAT3 upregulation in smokers and strong correlation with NF-κB activity in non-small cell lung cancer (NSCLC) tissues. TNFα treatment elevated EAAT3 in epithelial cells, while NF-κB inhibitors reduced its expression. Co-IP showed no direct EAAT3-xCT interaction, indicating independent but synergistic roles in cystine/glutamate exchange.

Secondary Findings:

NF-κB inhibition paradoxically increased ACSL4 (a ferroptosis driver) and GPX4 (an antioxidant enzyme), creating sensitivity to GPX4 inhibitors. ROS accumulation experiments confirmed that NF-κB/EAAT3 suppression exacerbated oxidative stress, particularly under GSH depletion. In NSCLC patients, 87% of tumors showed elevated EAAT3 alongside NF-κB’s P65 subunit. Smoking exposure in mice and in vitro CSE/NNK treatment suppressed GPRC5A (a tumor suppressor) while elevating EAAT3, RelA, and BAX, linking inflammation to EAAT3 upregulation.

Interpretation:

NF-κB’s regulation of EAAT3 establishes a critical axis for maintaining GSH synthesis and resisting ferroptosis in lung cancer. This pathway enables cancer cells to survive oxidative stress, a hallmark of tumor microenvironments. The study highlights EAAT3 as a therapeutic target, with NF-κB inhibitors (e.g., QNZ) sensitizing tumors to ferroptosis inducers like RSL3. The findings also underscore smoking’s role in activating this axis via inflammation, offering insights into lung cancer pathogenesis in smokers.

Strengths:

The study integrates in vitro, in vivo, and clinical data, validating findings across multiple systems. Use of genetically engineered mice (Gprc5a–/–/SPC-dnIκBα) and public datasets strengthens translational relevance. Identification of NF-κB binding sites and functional validation via mutagenesis provides mechanistic clarity.

Limitations:

The focus on lung cancer limits generalizability to other malignancies. In vivo drug efficacy was not tested in combination therapies, and the paradoxical GPX4 upregulation under NF-κB inhibition requires further mechanistic exploration.

Design:

A longitudinal cohort study using data from the China Health and Retirement Longitudinal Study (CHARLS, 2011–2015) followed 5,430 participants aged ≥45 years. Exclusion criteria removed individuals with baseline CVD, missing biomarker data, or incomplete follow-up. Participants were categorized into four groups: non-diabetic/no CVD, non-diabetic/developed CVD, diabetic/no CVD, and diabetic/developed CVD. Air pollution exposure was estimated using the China High Air Pollution (CHAP) dataset, providing 5-year average pollutant concentrations at 0.1° grid resolution. ILR was calculated as CRP (mg/L) divided by HDL-C (mg/dL × 10), reflecting systemic inflammation and lipid dysfunction.

Procedures:

Air pollution exposure levels for PM1, PM2.5, PM10, and O3 were derived from spatial-temporal models. Statistical analyses included generalized linear models (GLM) to assess associations between pollutants, ILR, and CVD incidence. Three models were applied: unadjusted, sociodemographic/lifestyle-adjusted, and fully adjusted (including health metrics like BMI and blood pressure). Interaction terms tested ILR’s modifying effect on pollution-CVD relationships. Nonlinearity in ILR-CVD associations was evaluated using restricted cubic splines. Sensitivity analyses addressed regional economic disparities and residential mobility.

Primary Findings:

Diabetic participants had a 13.8% baseline CVD prevalence versus 8.5% in non-diabetics. Each interquartile range (IQR) increase in pollutants was associated with 19–28% higher CVD risk in diabetics: O3 (21%), PM1 (19%), PM10 (28%), and PM2.5 (19%). PM10 had the strongest effect, followed by O3 and PM2.5. ILR was positively linked to CVD (OR 1.019, 95% CI 1.001–1.037, p < 0.05), with a nonlinear relationship (p = 0.0381), indicating disproportionate risk at higher ILR values. Interaction analyses revealed ILR amplified pollution’s effects; for example, O3’s CVD risk rose from 1.16 to 1.27 with elevated ILR.

Secondary Findings:

CVD cases were older, more likely female, urban-residing, and centrally located in China, with higher CRP, triglycerides, and waist circumference, and lower HDL-C. Pollutants showed strong correlations (e.g., PM2.5 and PM10: r = 0.98), suggesting shared sources. Sensitivity analyses confirmed robustness except for O3 in subgroup analyses. Mean pollutant concentrations exceeded WHO guidelines, particularly PM2.5 (103.2 µg/m³ vs. 10 µg/m³ annual limit) and PM10 (60.21 µg/m³ vs. 20 µg/m³).

Interpretation:

The findings highlight synergistic effects of diabetes and air pollution on CVD risk, mediated by ILR. Mechanisms include pollution-induced systemic inflammation (elevated CRP), oxidative stress, and endothelial dysfunction, exacerbated by diabetes-related metabolic dysfunction. ILR’s nonlinear relationship suggests a threshold effect, where even modest increases in inflammation or lipid abnormalities significantly elevate risk. The study aligns with prior work on pollution’s role in metabolic inflammation but uniquely isolates diabetic populations, a high-risk group. ILR emerges as a novel biomarker for risk stratification.

Strengths:

The longitudinal design, large sample size (5,430 participants), and advanced statistical methods (e.g., interaction terms, restricted cubic splines) strengthen validity. The inclusion of multiple pollutants and ILR as a composite marker provides comprehensive insights into environmental and metabolic interactions.

Limitations:

Cross-sectional exposure assessment limits causal inference. Self-reported CVD diagnoses may introduce bias. Ecological pollution estimates (county-level) may not reflect individual exposure. Short follow-up period (four years) and lack of longitudinal ILR data are additional limitations.

Design:

The study employed a controlled experimental design to evaluate the effects of hardening protocols on CPC scaffold properties. Four groups (WA, VA, VW, VS) were tested using 3D-printed CPC lattices. Mechanical testing, surface characterization, in vitro ion release, osteogenic activity assays, and gene-delivery experiments were conducted. HEK 293T cells and MC3T3 osteoblasts were used to assess cellular interactions, while flow cytometry and luciferase assays measured transfection efficiency and gene expression over time.

Procedures:

Mechanical properties (compressive strength, Young’s modulus) were assessed via universal testing machines. Scanning electron microscopy (SEM) and BET analysis quantified surface morphology and specific surface area (SSA). In vitro incubation in DMEM measured calcium ion release and pH changes. Alkaline phosphatase (ALP) activity assays evaluated osteogenic differentiation. Gene delivery used lyophilized polyplexes (PEI-plasmid complexes) applied to CPC scaffolds, with transfection efficiency measured via flow cytometry and luciferase expression tracked over eight days. Centrifugation experiments confirmed polyplex adsorption to scaffold surfaces.

Primary Findings:

VS scaffolds exhibited the highest compressive strength (21.28 MPa) and Young’s modulus (233.3 MPa), outperforming WA (6.54 MPa, 100.5 MPa) and VA (12.12 MPa, 147.8 MPa). SEM revealed strut cracks in WA scaffolds but smoother surfaces in VA, VW, and VS. BET analysis showed WA had the highest SSA (34.07 m²/g), while VS balanced mechanical robustness (13.59 m²/g). ALP activity correlated with mechanical performance, with VS scaffolds inducing the highest osteogenic activity (0.093 ng/mg DNA). Gene delivery experiments demonstrated transfection efficiencies of 13.4% (VW) and 12.97% (VS) in discs, but lattice structures reduced efficiency to ~1.2% due to polyplex adsorption. Luciferase assays showed sustained gene expression over eight days, with peak activity in HEK cells on day 4 (1,200 RLU/µL) and MC3T3 cells on day 6 (850 RLU/µL).

Secondary Findings:

VA scaffolds caused the greatest calcium depletion (20.25%) and pH increase (8.15), while VS mitigated these effects. SEM confirmed polyplex aggregates adhered to scaffold struts, reducing cellular uptake by 40–60%. Centrifugation experiments validated polyplex sequestration by CPC particulates. Surface morphology influenced osteogenesis: VS’s needle-like nanocrystals and reduced calcium absorption correlated with higher ALP activity compared to WA’s plate-like structures. Despite high SSA in WA, its mechanical weakness limited practical utility.

Interpretation:

VS hardening emerged as optimal due to SBF-induced mineralization, enhancing mechanical strength and surface stability. The inverse relationship between SSA and mechanical performance highlights a trade-off between surface area and structural integrity. Polyplex adsorption on CPC surfaces, exacerbated by lattice geometry, hindered gene delivery, suggesting surface functionalization or alternative delivery vectors (e.g., lipid nanoparticles) are critical. The study underscores the importance of scaffold design in balancing osteogenic stimulation and therapeutic efficacy.

Strengths:

Comprehensive evaluation of hardening protocols, integration of mechanical, biological, and gene-delivery assessments, and use of clinically relevant models (e.g., HEK and MC3T3 cells) strengthen the findings. The inclusion of in vitro ion release and pH studies provides insights into scaffold biocompatibility.

Limitations:

In vivo validation is lacking, and the study did not test BMP-2 plasmid delivery directly. The reduced transfection efficiency in lattice structures compared to discs indicates geometry-dependent challenges, requiring further optimization. Additionally, long-term in vivo degradation and osteointegration remain unexplored.

Design:

An in vitro experimental design was employed, exposing HSF and A-549 cells to CaTiO₃NPs for 48 hours. The study used a concentration range up to 2000 µg/mL to assess cellular responses. Characterization of CaTiO₃NPs confirmed their spherical morphology, average size of 88.79 nm, and zeta potential of -3.38 mV, ensuring stability in aqueous media.

Procedures:

Cytotoxicity was measured via the Sulforhodamine B (SRB) assay. Genotoxicity was assessed using the alkaline Comet assay to quantify DNA damage (tail length, %DNA in tail, tail moment). Reactive oxygen species (ROS) generation was analyzed fluorometrically. Quantitative real-time PCR (qRT-PCR) evaluated apoptotic gene expression (p53, Bax, Bcl2). Statistical significance was determined using ANOVA and Student’s t-test.

Primary Findings:

CaTiO₃NPs exhibited low cytotoxicity in both cell lines, with IC₅₀ values exceeding 1000 µg/mL (A-549 IC₅₀: 1670.65 µg/mL). Genotoxicity analysis revealed significant DNA damage in A-549 cells at IC₅₀ concentrations, with increased tail length (15.57 ± 1.88 px), %DNA in tail (29.15 ± 2.71%), and tail moment (16.56 ± 2.32) compared to controls. ROS levels were markedly elevated in A-549 cells but unchanged in HSF cells. Gene expression analysis showed upregulated p53 (8.60-fold) and Bax (4.47-fold) alongside downregulated Bcl2 (0.44-fold) in A-549 cells, indicating apoptosis. HSF cells exhibited only modest Bcl2 upregulation (1.77-fold) with no significant changes in p53 or Bax.

Secondary Findings:

The lack of significant ROS elevation or DNA damage in HSF cells suggests inherent differences in antioxidant defenses between cancer and normal cells. The IC₅₀ values highlight minimal toxicity at lower concentrations, critical for clinical applications. The Comet assay results correlated strongly with ROS levels and apoptotic gene expression in A-549 cells.

Interpretation:

CaTiO₃NPs selectively induced oxidative stress, DNA damage, and apoptosis in A-549 cells while sparing HSF cells, indicating potential as a lung cancer therapeutic. The p53-mediated apoptotic pathway activation in cancer cells suggests exploitation of their genetic vulnerabilities. The disparity in ROS responses between cell types implies that cancer cells may have impaired antioxidant systems, exacerbating nanoparticle-induced oxidative stress.

Strengths:

The study employed a comprehensive approach, integrating cytotoxicity, genotoxicity, and molecular analyses. Using both cancer and normal cells provided critical insights into selectivity. The Comet assay and qRT-PCR methods ensured robust assessment of DNA damage and apoptotic mechanisms.

Limitations:

The 48-hour exposure period may not reflect long-term effects. In vivo validation is needed to confirm safety and efficacy in complex biological systems. Additionally, the study did not explore nanoparticle internalization mechanisms or long-term genomic instability.

Design:

The study employs a materials synthesis and characterization approach, combining chemical extraction, thermal processing, and adsorption testing. CKD-derived calcium is extracted via citric acid chelation, followed by calcination to form calcium carbonate and carbon. The mixture is reacted with ortho-phosphoric acid to produce HAP-C, which undergoes heat treatment at 400°C, 500°C, or 700°C under inert conditions. Adsorption experiments assess RB and LV removal efficiency under varying pH, dose, and concentration conditions. Statistical analyses (quantile regression, non-linear regression) and thermodynamic/kinetic modeling validate adsorption mechanisms.

Procedures:

Key steps include: (1) calcium extraction from CKD using 1M citric acid at pH 3; (2) calcination of the chelate at 450°C to produce CaCO₃ and carbon; (3) reaction with ortho-phosphoric acid to form HAP-C; (4) heat treatment at 400–700°C to optimize crystallinity and surface properties. Characterization uses FTIR, XRD, BET, TEM, TGA, and zeta potential analysis. Adsorption trials test RB (50–100 ppm) and LV (25–100 ppm) removal under optimal conditions (pH 7 for RB, pH 4 for LV). Regeneration tests use ethanol to assess reusability over four cycles.

Primary Findings:

HAP-C 700 A (heat-treated at 700°C) exhibits the highest surface area (107.9 m²/g), pore volume (0.1832 cm³/g), and mesopore diameter (124.52 Å), enabling superior adsorption. RB removal reaches 96% at pH 7, while LV removal peaks at 83.8% at pH 4. Adsorption follows pseudo-second-order kinetics, indicating surface reaction control. The Sips isotherm model best describes adsorption behavior, reflecting heterogeneous surface energetics. Thermodynamic analysis confirms exothermic, spontaneous adsorption (ΔG < 0). Regeneration tests show sustained RB removal efficiency over four cycles, with LV adsorption dropping 20% post-second cycle due to stronger electrostatic binding.

Secondary Findings:

XRD confirms HAP crystallinity with a Ca/P ratio of 1.66, close to pure hydroxyapatite. BET analysis reveals pore size reduction in non-carbonized HAP samples (HAP 700, HAP 900) due to crystal growth, limiting their adsorption capacity. FTIR identifies functional groups (OH, PO₄³⁻) involved in hydrogen bonding and electrostatic interactions. Binary adsorption tests show no significant competition between RB and LV, with comparable removal efficiencies to single-component systems. Tap water tests improve LV removal slightly, attributed to ionic interactions with dissolved minerals.

Interpretation:

The nanocomposite’s mesoporous structure and carbon matrix enhance adsorption by providing abundant active sites and improving ion accessibility. The carbon phase stabilizes HAP, preventing agglomeration and preserving surface area. The optimal heat treatment (700°C) balances crystallinity and porosity, maximizing adsorption capacity. CKD utilization reduces reliance on conventional calcium sources, lowering costs and environmental impact. The adsorption mechanism involves electrostatic interactions (RB’s zwitterionic form, LV’s positive charge at pH 4) and physisorption (Sips model, ΔG < 0).

Strengths:

The method simplifies HAP-C synthesis by using a single precursor (CKD) and in-situ carbon formation, reducing steps and chemical waste. The nanocomposite outperforms or matches other hydroxyapatite-based adsorbents, particularly waste-derived materials like eggshell hydroxyapatite. The study’s interdisciplinary approach bridges materials science and environmental engineering, offering a scalable solution for industrial waste valorization.

Limitations:

Adsorption tests focus on two pollutants; broader contaminant testing is needed. Real-world water matrices (e.g., high salinity) may affect performance. Long-term stability and large-scale synthesis feasibility require further evaluation. LV’s reduced regeneration efficiency highlights the need for alternative eluents or surface modifications.

Design:

A prospective cohort study surveyed 656 first-year medical students (aged 17–23 years, 78.05% female) across two phases: September–December 2021 (traditional learning) and January–March 2022 (distance learning). Participants were enrolled in medical, pediatric, medico-preventive, dental, and pharmaceutical faculties.

Procedures:

Standardized tools included the State-Trait Anxiety Inventory (STAI), Beck Depression Inventory (BDI), and Cantril Self-Anchoring Scale for life quality. An original questionnaire assessed stressors, coping mechanisms, and support measure effectiveness. Data were analyzed using statistical methods to compare anxiety, depression, and quality-of-life metrics between phases and subgroups.

Primary Findings:

During traditional learning, 74.09% of students exhibited high reactive anxiety (mean STAI score 51.93, moderate-to-severe anxiety). Females reported significantly higher anxiety (52.69 vs. 49.27 in males, p < 0.05) and depression (mean BDI score 13.87 vs. 8.72 in males, p < 0.05). Medical, pediatric, and medico-preventive students showed stronger stress responses than dental/pharmaceutical peers. Primary stressors included fear of infection (83.21%), concern for elderly relatives (83.91%), and uncontrolled viral spread (63.21%). Over half (55.5%) experienced mild-to-severe depression, with a strong correlation between anxiety and depression (r = 0.959). Vegetative symptoms like sleep disturbances (47.13%) and fatigue (51.72%) were prevalent, lowering life quality (mean Cantril score 6.99). After transitioning to distance learning, anxiety dropped to 34.92% (mean STAI 40.89), depression severity normalized (mean BDI 8.93), and life quality improved (mean Cantril score 8.61).

Secondary Findings:

Distance learning modalities (online lectures, remote testing), financial aid, and psychological support were most effective in reducing stress. Ineffective measures included mandatory thermometry and attendance monitoring. Gender disparities persisted, with females reporting more psycho-vegetative symptoms. Faculty differences were attributed to perceived exposure risks and academic pressures.

Interpretation:

The pandemic exacerbated anxiety and depression among medical students, particularly females and those in clinical fields. Distance learning mitigated stress by reducing infection risks and academic pressures. Financial strain and caregiving responsibilities further compounded mental health challenges. The strong anxiety-depression correlation underscores the need for integrated mental health support. Effective interventions align with prior research on distance education benefits during crises, though socioeconomic barriers may limit equitable access.

Strengths:

Prospective design, large sample size (n=656), and validated tools (STAI, BDI) ensured robust data. Direct comparison of traditional vs. distance learning phases provided actionable insights.

Limitations:

Self-reported data may introduce bias. Underrepresentation of male students (21.95%) and exclusion of senior students limit generalizability. Cross-sectional design precludes causal inferences.